VERA
Vera Therapeutics, Inc.
Latest Form 4:Sale$2.0MbyFordyce Marshall (PRESIDENT AND CEO) · filed Aug 12, 2026
Vera Therapeutics, Inc. (VERA) has 30 SEC Form 4 filings (49 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Aug 12, 2026.
The most active filer is PRESIDENT AND CEO Fordyce Marshall with 5 filings. Insiders have net sold $5.8M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Gary Barrera
- Employees:152
- HQ:Brisbane, CA, US
- IPO:2021-05-14
Insider Buying
$250K
reported purchases (SEC code P)
Insider Selling
$7.7M
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Market Cap
$2.3B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| PRESIDENT AND CEO | Sale | 46,250 | $2.0M | Aug 12 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 18,500 | $702K | Aug 12 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 18,500 | $680K | Aug 12 | SEC ↗ | |
| PRESIDENT AND CEO | Sale | 22,951 | $1.0M | Apr 15 | SEC ↗ | |
Young Joseph RFirst in 3 months | SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 3,117 | $131K | Feb 25 | SEC ↗ |
Fordyce MarshallFirst filing | PRESIDENT AND CEO | Sale | 16,925 | $711K | Feb 25 | SEC ↗ |
| Chief Regulatory Officer | Sale | 2,187 | $92K | Feb 25 | SEC ↗ | |
Brenner RobertFirst filing | Chief Medical Officer | Sale | 2,151 | $90K | Feb 25 | SEC ↗ |
Grant SeanFirst filing | CHIEF FINANCIAL OFFICER | Sale | 4,949 | $208K | Feb 25 | SEC ↗ |
JOHNSON DAVID LEEFirst filing | Chief Operating Officer | Sale | 2,579 | $108K | Feb 25 | SEC ↗ |
Skelton Laurence MatthewFirst filing | Chief Commercial Officer | Sale | 1,582 | $66K | Feb 25 | SEC ↗ |
| Chief Regulatory Officer | Sale | 10,000 | $501K | Dec 17 | SEC ↗ | |
| Director | Purchase | 5,882 | $250K | Dec 15 | SEC ↗ | |
| Chief Regulatory Officer | Sale | 10,000 | $453K | Dec 10 | SEC ↗ | |
Turner William D.First filing | Chief Regulatory Officer | Sale | 10,000 | $400K | Dec 4 | SEC ↗ |
Carter Jason SFirst filing | Chief Legal Officer | Sale | 3,864 | $107K | Nov 25 | SEC ↗ |
Young Joseph RFirst filing | SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 15,000 | $436K | Nov 13 | SEC ↗ |
Related companies
Vera Therapeutics, Inc. is in the Healthcare sector.